These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of Ezetimibe on Stabilization and Regression of Intracoronary Plaque - The ZIPANGU Study. Ueda Y; Hiro T; Hirayama A; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K; Circ J; 2017 Oct; 81(11):1611-1619. PubMed ID: 28592751 [TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study. Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K; J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy. Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864 [TBL] [Abstract][Full Text] [Related]
10. Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial. Nakano Y; Yamamoto M; Matoba T; Katsuki S; Nakashiro S; Takase S; Akiyama Y; Nagata T; Mukai Y; Inoue S; Oi K; Higo T; Takemoto M; Suematsu N; Eshima K; Miyata K; Usui M; Sadamatsu K; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Tsutsui H J Atheroscler Thromb; 2023 Aug; 30(8):907-918. PubMed ID: 36450458 [TBL] [Abstract][Full Text] [Related]
11. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial. Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M; Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events. Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. Endo H; Dohi T; Miyauchi K; Kuramitsu S; Kato Y; Okai I; Yokoyama M; Yokoyama T; Ando K; Okazaki S; Shimada K; Suwa S; Daida H J Cardiol; 2019 Aug; 74(2):102-108. PubMed ID: 30737184 [TBL] [Abstract][Full Text] [Related]
18. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER). Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705 [TBL] [Abstract][Full Text] [Related]
19. Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression. Masson W; Lobo M; Siniawski D; Molinero G; Masson G; Huerín M; Nogueira JP Lipids Health Dis; 2020 May; 19(1):111. PubMed ID: 32460779 [TBL] [Abstract][Full Text] [Related]
20. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME. Japaridze L; Sadunishvili M; Megreladze I Georgian Med News; 2016 Mar; (252):15-22. PubMed ID: 27119829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]